GORE® ENFORM Biomaterial Product Study

Pre-procedure Inclusion Criteria

The subject is / has

• At least 18 years old at the time of informed consent. Minimum age required by state regulations (as applicable).
• An expected scored Class I (Clean) surgical wound using CDC Surgical Wound Classification system.
• A planned implant with GORE® ENFORM Biomaterial for a single site ventral or hiatal hernia repair as suture line reinforcement.
• An expected scored Grade 1 or Grade 2 using the Ventral Hernia Working Group Grading system.
• Willing to provide informed consent and comply with follow-up requirements.

Pre-procedure Exclusion Criteria

The subject is / has

• Treated in another drug or medical device study within 1 year of study enrollment.
• Implanted with GORE® ENFORM Biomaterial in the reconstruction of cardiovascular defects.
• Hernia repair expected to be performed as part of a bridged procedure (i.e., expected inability to perform primary closure of fascia or crura, patients requiring permanent support from the device).
• A BMI >40.
• Evidence of a systemic infection.
• Cirrhosis or undergoing dialysis.
• A wound-healing disorder.
• Immunocompromised such as, with HIV or transplant, or receiving chemo or radiation therapy.
• Expected to undergo mesh implantation in conjunction with any bariatric procedure and / or panniculectomy procedure.
• A stoma.
• Co-morbid conditions that may limit their ability to comply with study and follow-up requirements.
• Positive pregnancy or lactation status as confirmed by site standard of care.
• Hernias requiring treatment within multiple body regions or expected use of multiple hernia mesh devices.

Post-procedure Inclusion Criteria

At the time of index procedure, the subject is / has:

• At least 18 years old. Minimum age required by state regulations (as applicable).
• Implanted with GORE® ENFORM Biomaterial for a single site ventral or hiatal hernia repair as suture-line reinforcement on or before 365 days prior to site protocol amendment 3 approval date.
• Unless there is an Informed Consent waiver issued by the Institutional Review Board (IRB), an Informed Consent Form (ICF) signed by subject.

Post-procedure Exclusion Criteria

At the time of index procedure, the subject is / has:

• Treated in another drug or medical device study within 1 year of study enrollment.
• Implanted with GORE® ENFORM Biomaterial in the reconstruction of cardiovascular defects.
• Hernia repair that was performed as part of a bridged procedure (i.e., inability to perform primary closure of fascia or crura, patients requiring permanent support from the device).
• A BMI >40.
• Evidence of a systemic infection.
• Cirrhosis or undergoing dialysis.
• A wound-healing disorder.
• Immunocompromised such as, with HIV or transplant, or receiving chemo or radiation therapy.
• Underwent mesh implantation in conjunction with any bariatric procedure and / or panniculectomy procedure.
• A stoma.
• Co-morbid conditions that may limit their ability to comply with study and follow-up requirements.
• Positive pregnancy or lactation status as confirmed by site standard of care.
• Hernias requiring treatment within multiple body regions or expected use of multiple hernia mesh devices.